BioTechX Europe stands as Europe’s largest congress encompassing diagnostics, precision medicine, and digital transformation within pharmaceutical development and healthcare.
Through sustained engagement, strong relationships have been cultivated with local entities such as the Canton of Basel, Novartis, Roche, and numerous incubators, facilitating comprehensive coverage of the drug development pipeline.
In 2024, the 2-day event returns to Basel, the pharmaceutical center of Europe, convening over 3500 leaders, 400 speakers, and 100 start-ups in a single venue. The BioTechX Europe Congress features prominent speakers from the top 50 pharmaceutical companies, biotechs, healthcare systems, and academic groups, fostering extensive networking opportunities.